EurekaMag.com logo
+ Translate

How and when is immunotherapy for pollen allergy carried out?


, : How and when is immunotherapy for pollen allergy carried out?. Medizinische Klinik 75(21): 751-754

Hyposensitization with semi-depot extracts was effective in 164 of 201 (81,4%) grass pollen sensitive patients. In 54,1% the results were very good and good. Patients were treated perennially for two years. The success of treatment was evaluated by a questionnaire. The results show that treatment will be most effective if the disease has been of relative short duration, if patients are young, if the final dosage is high and a high total dosage is reached, and if side effects only occur as local reactions. The frequency of symptoms and their improvement are described.

(PDF 0-2 workdays service)

Accession: 043283577

PMID: 7453622

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Berto, P.; Passalacqua, G.; Crimi, N.; Frati, F.; Ortolani, C.; Senna, G.; Canonica, G.Walter., 2006: Economic evaluation of sublingual immunotherapy vs symptomatic treatment in adults with pollen-induced respiratory allergy: the Sublingual Immunotherapy Pollen Allergy Italy (SPAI) study. Few data are available on the pharmacoeconomic aspects of immunotherapy. To evaluate, from the health care system and societal perspectives, the costs and consequences of sublingual immunotherapy (SLIT) added to pharmacotherapy compared with drugs...

Løwenstein, H.; Wihl, J.A.; Bache Billesbølle, K.; Bøwadt, H., 1984: Rationale for specific immunotherapy of grass pollen allergy with extracts of rye pollen. Skin test reactivity and immunochemical relationship between pollen allergens from rye and other common grasses. In immunotherapy of grass pollen allergy, an extract of rye (Secale cereale) is often included. The aim of this study was to investigate by skin prick test (SPT) and immunochemical methods whether rye pollen contains specific allergens justifying...

Lowenstein H.; Wihl J A.; Billesbolle K.B.; Bowadt H., 1984: Rationale for specific immunotherapy of grass pollen allergy with extracts of rye secale cereale pollen skin test reactivity and immunochemical relationship between pollen allergens from rye and other common grasses. In immunotherapy of grass pollen allergy, an extract of rye is often included. The aim of this study was to investigate by skin prick test (SPT) and immunochemical methods whether rye pollen contains specific allergens justifying the use of this e...

Senna, G.Enrico.; Calderon, M.; Milani, M., 2011: Allergy immunotherapy tablet: Grazax® for the treatment of grass pollen allergy. Immunotherapy is the only treatment for allergy that alters the natural course of this disease. Sublingual immunotherapy has been developed to make immunotherapy more suitable for allergic patients. In the largest clinical program ever conducted w...

Czarnecka-Operacz, M.; Jenerowicz, D.; Silny, W., 2008: Oral allergy syndrome in patients with airborne pollen allergy treated with specific immunotherapy. According to literature, approximately 20%-70% of patients sensitized to pollen allergens experience oral allergy syndrome (OAS) symptoms after eating raw fruits and vegetables. There is no standard treatment established for OAS except avoiding im...

Nowak Wegrzyn, A.H.; Mofidi, S.; Ma, S.; Bardina, L.; Beyer, K., 2004: Birch and ragweed pollen immunotherapy in the treatment of pollen-food allergy syndrome. Journal of Allergy & Clinical Immunology 113(2 Supplement): S146, February

Hakansson, L.; Heinrich, C.; Rak, S.; Venge, P., 1997: Priming of eosinophil adhesion in patients with birth pollen allergy during pollen season: Effect of immunotherapy. The adhesion of eosinophil granulocytes to E-selectin, vascular cell adhesion molecule-1 (VCAM-1), and intercellular adhesion molecule-1 (ICAM-1) was investigated before and during birch pollen season in 24 patients allergic to birch pollen who ha...

Håkansson, L.; Heinrich, C.; Rak, S.; Venge, P., 1997: Priming of eosinophil adhesion in patients with birch pollen allergy during pollen season: effect of immunotherapy. The adhesion of eosinophil granulocytes to E-selectin, vascular cell adhesion molecule-1 (VCAM-1), and intercellular adhesion molecule-1 (ICAM-1) was investigated before and during birch pollen season in 24 patients allergic to birch pollen who ha...

Modrzyński, M.; Zawisza, E.; Rapiejko, P.; Przybylski, G., 2003: Specific-pollen immunotherapy in the treatment of oral allergy syndrome in patients with tree pollen hypersensitivity. Over the last three decades several authors have described the existence of an association between sensitivity to different pollens and sensitivity to diverse edible vegetables. Most patients with birch pollen allergy report oral allergy symptoms...

Manzotti, G.; Pappacoda, A.; Dimatteo, M.; Scolari, C.; Riario-Sforza, G.G.; Incorvaia, C., 2015: Ultra short pre-seasonal subcutaneous immunotherapy and pre-coseasonal sublingual immunotherapy for pollen allergy: an evaluation of patient's preference in real life. Specific immunotherapy (SIT) efficacy and safety by subcutaneous (SCIT) and sublingual (SLIT) route is supported by literature data. Pre-coseasonal treatment is currently the more accepted option for pollen immunotherapy in terms of costs and pati...